Radford Jason W. 4
4 · GENOMIC HEALTH INC · Filed Jan 24, 2019
Insider Transaction Report
Form 4
Radford Jason W.
Chief Legal Officer
Transactions
- Sale
Common Stock
2019-01-22$70.97/sh−1,538$109,154→ 32,751 total - Sale
Common Stock
2019-01-22$71.95/sh−1,425$102,529→ 31,326 total
Footnotes (5)
- [F1]These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on November 15, 2018.
- [F2]Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- [F3]Represents weighted average sale price. Actual sale prices ranged from $70.52 to $71.48.
- [F4]Includes an aggregate of 24,447 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- [F5]Represents weighted average sale price. Actual sale prices ranged from $71.62 to $72.02.